(Q40629225)

22 September 2017

CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1 (English)

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

17 March 2024

1 reference

acute myeloid leukemia

1 reference

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

17 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

17 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

17 March 2024

author name string

Zeineb Gadhoum

1

1 reference

22 September 2017

Marie-Pierre Leibovitch

2

1 reference

22 September 2017

Junyuan Qi

3

1 reference

22 September 2017

Dominique Dumenil

4

1 reference

22 September 2017

Laetitia Durand

5

1 reference

22 September 2017

Serge Leibovitch

6

1 reference

22 September 2017

Florence Smadja-Joffe

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

2 October 2003

1 reference

22 September 2017

1 reference

22 September 2017

103

1 reference

22 September 2017

1059-1068

1 reference

22 September 2017

3

1 reference

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

22 September 2017

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910260208

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

17 March 2024

Acute myeloid leukemia

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1).

17 March 2024

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

CD44 and hyaluronan binding by human myeloid cells

17 March 2024

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

CD44 is the principal cell surface receptor for hyaluronate

17 March 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures

17 March 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Diverse effects of anti-CD44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vitro

17 March 2024

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages

17 March 2024

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

17 March 2024

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines

17 March 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

CDK inhibitors: positive and negative regulators of G1-phase progression

17 March 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Inhibitors of mammalian G1 cyclin-dependent kinases

17 March 2024

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia

17 March 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

DNA content histogram and cell-cycle analysis.

17 March 2024

29

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

The proteasome: a novel target for cancer chemotherapy

17 March 2024

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

17 March 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Stem cell repopulation efficiency but not pool size is governed by p27(kip1).

17 March 2024

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity

17 March 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1).

17 March 2024

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).

17 March 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells

17 March 2024

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis

17 March 2024

40

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Serum thrombopoietin levels in acute myeloid leukaemia.

17 March 2024

41

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells

17 March 2024

42

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

17 March 2024

43

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

17 March 2024

44

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

17 March 2024

45

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin

17 March 2024

48

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells

17 March 2024

50

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Monocytically Differentiating HL60 Cells Proliferate Rapidly before They Mature

17 March 2024

51

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid.

17 March 2024

52

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Cyclin E-CDK2 is a regulator of p27Kip1.

17 March 2024

53

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation

17 March 2024

54

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome

17 March 2024

55

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status.

17 March 2024

57

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity

17 March 2024

58

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

17 March 2024

59

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

CD44: from adhesion molecules to signalling regulators

17 March 2024

60

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

CD44 and adhesion of normal and leukemic CD34+ cells to bone marrow stroma

17 March 2024

61

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

The importance of cellular environment to function of the CD44 matrix receptor

17 March 2024

62

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.

17 March 2024

63

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation

17 March 2024

64

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages

17 March 2024

66

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta

17 March 2024

67

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

17 March 2024

68

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

17 March 2024

69

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1218

17 March 2024

Identifiers

1 reference

22 September 2017

1 reference